Trial
NCT05405192
Dostarlimab in Chemoresistant Gestational Trophoblastic Neoplasia
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Miami
Collaborators
GlaxoSmithKline
Condition
Gestational Trophoblastic Neoplasia
Intervention
Dostarlimab
Why stopped
PI is leaving the University.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-02-28